Analysis | Metabolite Name | Measured Value | Units | Gender | Condition |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 60211 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 73515 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 75111 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 83691 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 88507 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 90536 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 90882 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 90993 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 93535 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 94420 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 95476 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 96086 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 102223 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 103767 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 104448 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 105098 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 106070 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 106258 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 107660 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 112369 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 113486 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 113581 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 114642 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 114693 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 115323 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 118145 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 118478 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 119152 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 122540 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 122855 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 122930 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 123317 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 126011 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 126542 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 130714 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 131486 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 132426 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 132938 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 135279 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 136174 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 136876 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 137054 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 138060 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 138301 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 138638 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 140044 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 142227 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 143014 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 143244 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 145874 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 146345 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 147691 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 149131 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 149513 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 152002 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 153463 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 154028 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 155467 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 157239 | Peak area normalized | CHEAR | CHEAR |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 157239 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 157239 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 158827 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 158919 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 159323 | Peak area normalized | POOL | POOL |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 160042 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 160301 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 162015 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 162364 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 164138 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 164747 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 167583 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 169539 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 169892 | Peak area normalized | Female | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 170002 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 186346 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 195128 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 203555 | Peak area normalized | Male | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 203689 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 216430 | Peak area normalized | Female | asthmatic |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 218727 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 240371 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 255290 | Peak area normalized | Male | control |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 304515 | Peak area normalized | CHEAR | CHEAR |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 306611 | Peak area normalized | CHEAR | CHEAR |
Reversed phase POSITIVE ION MODE | gamma-glutamylleucine | 430387 | Peak area normalized | Female | control |